108 related articles for article (PubMed ID: 27029334)
1. A clinical case of combined treatment of a patient with breast cancer and metastases to the brain and meninges.
Moskvina EA; Naskhletashvili DR; Bekyashev AK; Medvedev SV; Belov DM; Gasparyan TG
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(1):83-87. PubMed ID: 27029334
[TBL] [Abstract][Full Text] [Related]
2. [Four cases of meningeal metastasis originating from breast cancer].
Kashiwagi S; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Nakamura M; Kawajiri H; Takashima T; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1917-9. PubMed ID: 23267929
[TBL] [Abstract][Full Text] [Related]
3. [Complex treatment of breast cancer patients with brain metastases].
Medvedev SV; Tkachev SI; Moskvina EA; Mikhina ZP; Naskhletashvili DR; Bulychkin PV; Romanov DS; Trofimova OP; Berdnik AV; Bykova YB; Gutnik RA; Yazhgunovich IP; Fedoseenko DI
Vopr Onkol; 2015; 61(6):965-7. PubMed ID: 26995988
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Effective Whole-Brain Irradiation and Lapatinib/Capecitabine Combination Therapy for HER2-Positive Breast Cancer with Multiple Brain Metastases].
Shibasaki M; Tanabe A; Toda T; Sakata H; Ijichi M; Kusaka K; Bandai Y
Gan To Kagaku Ryoho; 2015 Jun; 42(6):755-7. PubMed ID: 26199252
[TBL] [Abstract][Full Text] [Related]
5. [A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].
Fujita Y; Mizuta N; Sakaguchi K; Nakatsukasa K; Imai A; Umeda Y; Hamaoka A; Morita M; Shouji M; Goto M; Taguchi T
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1699-702. PubMed ID: 23152022
[TBL] [Abstract][Full Text] [Related]
6. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
7. CNS complications of breast cancer: current and emerging treatment options.
Kaal EC; Vecht CJ
CNS Drugs; 2007; 21(7):559-79. PubMed ID: 17579499
[TBL] [Abstract][Full Text] [Related]
8. Secondary gliosarcoma with massive invasion of meninges, skull base, and soft tissue, and systemic metastasis.
Oberndorfer S; Wöhrer A; Hainfellner JA; Calabek B; Tinchon A; Brandl I; Grisold W
Clin Neuropathol; 2013; 32(6):522-4. PubMed ID: 23743158
[No Abstract] [Full Text] [Related]
9. HSV-1 as a novel therapy for breast cancer meningeal metastases.
Kuruppu D; Tanabe KK
Cancer Gene Ther; 2015 Oct; 22(10):506-8. PubMed ID: 26384139
[TBL] [Abstract][Full Text] [Related]
10. [A case of HER2-positive breast cancer receiving lapatinib+capecitabine chemotherapy with ventriculoperitoneal shunting for hydrocephalus associated with brain metastases].
Makino T; Kawamura H; Yokoyama E; Kato Y; Nishina M
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1115-7. PubMed ID: 22790050
[TBL] [Abstract][Full Text] [Related]
11. Pertuzumab, trastuzumab and docetaxel reduced the recurrence of brain metastasis from breast cancer: a case report.
Senda N; Yamaguchi A; Nishimura H; Shiozaki T; Tsuyuki S
Breast Cancer; 2016 Mar; 23(2):323-8. PubMed ID: 26116144
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine therapy of central nervous system metastases from breast cancer.
Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
[TBL] [Abstract][Full Text] [Related]
13. [Meningeal carcinosis: early clinical manifestations of inflammatory cancer of the breast].
Pandolfi C; Colecchia M; Bolognini G; de Fazio P; Montanari G; Pollini F; Nalli G
Minerva Med; 1995; 86(7-8):319-22. PubMed ID: 7478076
[TBL] [Abstract][Full Text] [Related]
14. The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
Kaidar-Person O; Deal AM; Anders CK; Ewend MG; Dees EC; Camporeale J; Ramirez J; Benbow JM; Marks LB; Zagar TM
Breast J; 2018 May; 24(3):424-425. PubMed ID: 29251377
[No Abstract] [Full Text] [Related]
15. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
[TBL] [Abstract][Full Text] [Related]
16. Complete response of brain metastases from breast cancer overexpressing Her-2/neu to radiation and concurrent Lapatinib and Capecitabine.
Abboud M; Saghir NS; Salame J; Geara FB
Breast J; 2010; 16(6):644-6. PubMed ID: 21070441
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
Rivera E; Meyers C; Groves M; Valero V; Francis D; Arun B; Broglio K; Yin G; Hortobagyi GN; Buchholz T
Cancer; 2006 Sep; 107(6):1348-54. PubMed ID: 16909414
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology.
Kaplan MA; Isikdogan A; Koca D; Kucukoner M; Gumusay O; Yildiz R; Dayan A; Demir L; Geredeli C; Kocer M; Arslan UY; Inal A; Akman T; Coskun U; Sener N; Inanc M; Elkiran ET; Ozdemir NY; Durnalı AG; Suner A; Alici S; Tarhan MO; Boruban C; Oksuzoglu B; Urakci Z
Breast Cancer; 2014 Nov; 21(6):677-83. PubMed ID: 23335064
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer.
Niravath P; Tham YL; Wang T; Rodriguez A; Foreman C; Hilsenbeck SG; Elledge R; Rimawi M
Oncologist; 2015 Jan; 20(1):13. PubMed ID: 25378456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
